<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
Pierre‐Antoine Juge(Inserm), Annick Clément(Inserm), Sébastien Ottaviani(Inserm), Esther Ebstein(Inserm), B. Wallaert(Target (United States)), Nathalie Saidenberg-Kermanac’h(Inserm), Ramcés Falfán‐Valencia(Instituto Nacional de Enfermedades Respiratorias), Ivette Buendía-Roldán(Inserm), Aline Frazier(Inserm), Vincent Cottin(Université Claude Bernard Lyon 1), Shigeto Tohma(National Sagamihara Hospital), Gabriel Thabut(Inserm), Mayra Mejía(Inserm), Claire Dromer(Inserm), S. Marchand‐Adam(Centre Hospitalier Universitaire de Tours), Dimitrios T. Boumpas(National and Kapodistrian University of Athens), Serge Amselem(Inserm), Steven Gazal(University of Southern California), H. Lioté(Inserm), Nadia Nathan(Inserm), Marie‐Christophe Boissier(Inserm), Yannick Allanore(Inserm), Hilario Nunès(Assistance Publique – Hôpitaux de Paris), Evgenia Dobrinskikh(University of Colorado Anschutz Medical Campus), Enrique Ambrocio-Ortiz(Inserm), Hiroshi Furukawa(Aichi Medical University), Christophe Richez(Centre National de la Recherche Scientifique), Κατερίνα Αντωνίου(University of Crete), Martin Soubrier(Centre Hospitalier Universitaire de Clermont-Ferrand), Lidwine Wémeau-Stervinou(Target (United States)), Dominique Valeyre(Inserm), Effrosyni D. Manali(National and Kapodistrian University of Athens), Caroline Kannengiesser(Inserm), Montserrat I. González-Pérez(Inserm), Joanne van der Vis(Inserm), Thierry Schaeverbeke(Centre Hospitalier Universitaire de Bordeaux), Jean Sibilia(Immunologie, Immunopathologie et Chimie Thérapeutique), Jorge Rojas‐Serrano(Inserm), Pascal Richette(Inserm), Raphaël Borie(Inserm), René‐Marc Flipo(Université de Lille), Yaping Wang(Huashan Hospital), Joyce Lee(Inserm), Jan C. Grutters(University Medical Center Utrecht), Yaël A de Man(Inserm), Shomi Oka(University of Tsukuba), Coline H.M. van Moorsel(Inserm), T. Karageorgas(Inserm), Spyros A. Papiris(University College Dublin), Naoyuki Tsuchiya(University of Tsukuba)
Cited by 501
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
|New England Journal of Medicine|2019|2.3k